Cite
HARVARD Citation
Combier, A. et al. (n.d.). AB0462 IMMUNIZATIONTO RITUXIMAB IS MORE FREQUENT IN AUTOIMMUNE SYSTEMIC AUTOIMMUNE DISEASES THAN IN RHEUMATOID ARTHRITIS AND MAY BE MANAGED BY SWITCHING FROM RITUXIMAB TO OFATUMUMAB. Annals of the rheumatic diseases. p. 1695. [Online].